Skip to content

Clinical trials

Phase 4 Hepatitis B trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 4 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20091
20101
20121
20141
20162
20171
20181
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Laval University2
University of British Columbia2
Cangene Corporation1
Jordan Feld1
Mount Sinai Hospital, Canada1
St. Joseph's Health Care London1
University Health Network, Toronto1
ViiV Healthcare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B14
Diphtheria2
Haemophilus Infections2
Poliomyelitis2
Tetanus2
Acquired Immunodeficiency Syndrome1
Diabetes Mellitus, Type 21
Hepatitis A1
Hepatitis C1
Hepatitis C, Chronic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.